(Q36158192)

12 August 2017

A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice (English)

1 reference

12 August 2017

1 reference

Hardy B

1

1 reference

12 August 2017

Kovjazin R

2

1 reference

12 August 2017

Raiter A

3

1 reference

12 August 2017

Ganor N

4

1 reference

12 August 2017

Novogrodsky A

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Proceedings of the National Academy of Sciences of the United States of America

12 August 2017

1 reference

12 August 2017

94

1 reference

12 August 2017

11

1 reference

12 August 2017

5756-5760

1 reference

The SCID mouse: relevance as an animal model system for studying human disease.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

Amplification of the immune response by agonistic antibodies.

2 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.11.5756

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.11.5756

Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

Demonstration of MHC class I-specific cytolytic activity in IL-2-activated NK1+CD3+ cells and evidence of usage of T and NK cell receptors.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=20852

In vivo administration of anti-CD3 prevents malignant progressor tumor growth

23 September 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.11.5756

Propagation of large numbers of T cells with natural killer cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.94.11.5756

Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3

21 January 2018

1 reference

12 December 2020

Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma

1 reference

12 December 2020

Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice

1 reference

12 December 2020

Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes

1 reference

12 December 2020

Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.94.11.5756

1 reference

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

9159146

1 reference